stockrow
Friday 6 November 2026
Export UFPT’s income statement to Excel — free account
UFP Technologies, Inc.
UFPT Healthcare Medical Devices
UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.
- Revenue
- +11.6%
- EPS
- +25.6%
- Free cash flow
- −35.8%
- Total debt
- −40.2%
Quarter to September 2026, against a year earlier
302.36
2.54
+0.85%
Follow UFPT
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
— | 4 | 5 | 5 |
+8 more TTM periods Free account |
| 0.00% | 17.05% | 17.17% | 17.82% | ||
| 11.46% | 10.98% | 10.42% | 10.64% | ||
ROIC |
11.20% | 10.29% | 10.15% | 10.44% | |
Return on Tangible Assets |
33.01% | 30.96% | 30.43% | 33.28% | |
Average Days of Receivables |
54.60 | 67.82 | 61.48 | 53.42 | |
Free Cash Flow per Share |
0.00 | 7.95 | 9.01 | 10.26 | |
Free Cash Flow |
— | 61.50 | 69.55 | 79.03 | |
Capital Expenditures |
— | (10.08) | (11.75) | (12.87) | |
| Other line items | |||||
Cash ROIC |
0.00% | 10.20% | 11.40% | 13.31% | |
Accounts Receivable Turnover |
7.05 | 6.19 | 6.10 | 6.78 | |
Accounts Payable Turnover |
16.50 | 16.24 | 15.01 | 17.81 | |
Inventory Turnover |
5.01 | 4.88 | 4.75 | 4.96 | |
Average Days of Payables |
20.95 | 26.64 | 23.79 | 20.50 | |
Days of Inventory on Hand |
77.62 | 80.89 | 78.64 | 73.32 | |
Tax Rate |
(0.18) | (0.18) | (0.18) | (0.17) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
13.53% | 13.27% | 13.10% | 12.85% | |
Share Based Compensation of Revenue |
0.00% | 1.63% | 1.54% | 1.47% | |
Interest Coverage |
14.64 | 12.40 | 10.60 | 9.42 | |
Operating CF/Net income |
0.00 | 0.99 | 1.18 | 1.35 | |
Depreciation/Fixed assets |
0.00 | 0.26 | 0.25 | 0.24 | |
Capex/Depreciation |
— | (0.51) | (0.60) | (0.67) | |
Revenue per Share |
83.85 | 81.61 | 78.86 | 78.23 | |
Operating CF per Share |
0.00 | 9.25 | 10.53 | 11.93 | |
Capex per Share |
0.00 | (1.30) | (1.52) | (1.67) | |
Capex to Sales |
0.00 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026